메뉴 건너뛰기




Volumn 75, Issue 4, 2011, Pages 286-293

Vitamin D supplementation in CKD

Author keywords

CKD; SHPT; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALFACALCIDOL; CALCITRIOL; COLECALCIFEROL; DOXERCALCIFEROL; ERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 23; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE; PLACEBO; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

EID: 79960943471     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.2379/CN106602     Document Type: Article
Times cited : (7)

References (69)
  • 2
    • 4644221457 scopus 로고    scopus 로고
    • CKD and the risks of death, cardiovascular events, and hospitalization
    • Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. CKD and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-1305.
    • (2004) N Engl J Med , vol.351 , pp. 1296-1305
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3    McCulloch, C.E.4    Hsu, C.Y.5
  • 3
    • 34249080680 scopus 로고    scopus 로고
    • Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population
    • Zhang L, Zhao F, Yang Y, Qi L, Zhang B, Wang F, Wang S, Liu L, Wang H. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis. 2007; 49: 786-792.
    • (2007) Am J Kidney Dis , vol.49 , pp. 786-792
    • Zhang, L.1    Zhao, F.2    Yang, Y.3    Qi, L.4    Zhang, B.5    Wang, F.6    Wang, S.7    Liu, L.8    Wang, H.9
  • 5
    • 39149122212 scopus 로고    scopus 로고
    • Hypertension and kidney disease: a deadly connection
    • Barri YM. Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep. 2008; 10: 39-45.
    • (2008) Curr Hypertens Rep , vol.10 , pp. 39-45
    • Barri, Y.M.1
  • 9
    • 33845700085 scopus 로고    scopus 로고
    • Prevalence of abnormal serum vitamin D, PTH, Ca, and Pi in patients with CKD: results of the study to evaluate early kidney disease
    • Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. Prevalence of abnormal serum vitamin D, PTH, Ca, and Pi in patients with CKD: results of the study to evaluate early kidney disease. Kidney Int. 2007; 71: 31-38.
    • (2007) Kidney Int , vol.71 , pp. 31-38
    • Levin, A.1    Bakris, G.L.2    Molitch, M.3    Smulders, M.4    Tian, J.5    Williams, L.A.6    Andress, D.L.7
  • 10
    • 84884828469 scopus 로고    scopus 로고
    • Photobiology of vitamin D
    • Feldman D, Pike JW, Glorieux FH (eds). 2nd Edition, NewYork: Elsevier Press
    • Holick M. Photobiology of vitamin D. In: Feldman D, Pike JW, Glorieux FH (eds). Vitamin D. 2nd Edition.NewYork: Elsevier Press; 2005. p. 37-46.
    • (2005) Vitamin D , pp. 37-46
    • Holick, M.1
  • 11
    • 54949087469 scopus 로고    scopus 로고
    • Vitamin D receptor ligand therapy in chronic kidney disease
    • Gonzalez E. Vitamin D receptor ligand therapy in chronic kidney disease. Clin Nephrol. 2008; 70: 271-283.
    • (2008) Clin Nephrol , vol.70 , pp. 271-283
    • Gonzalez, E.1
  • 12
    • 67651049740 scopus 로고    scopus 로고
    • Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U"
    • Cozzolino M, Brandenburg V. Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U". Clin Nephrol. 2009; 71: 593-601.
    • (2009) Clin Nephrol , vol.71 , pp. 593-601
    • Cozzolino, M.1    Brandenburg, V.2
  • 13
    • 34548202165 scopus 로고    scopus 로고
    • Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
    • Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007; 7: 684-700.
    • (2007) Nat Rev Cancer , vol.7 , pp. 684-700
    • Deeb, K.K.1    Trump, D.L.2    Johnson, C.S.3
  • 15
    • 0023805793 scopus 로고
    • Extra-renal production of calcitriol in chronic renal failure
    • Dusso A, Lopez-Hilker S, Rapp N, Slatopolsky E. Extra-renal production of calcitriol in chronic renal failure. Kidney Int. 1988; 34: 368-375.
    • (1988) Kidney Int , vol.34 , pp. 368-375
    • Dusso, A.1    Lopez-Hilker, S.2    Rapp, N.3    Slatopolsky, E.4
  • 19
    • 34948882837 scopus 로고    scopus 로고
    • Nonclassical aspects of differential VDR activation: implications for survival in patients with CKD
    • Andress D. Nonclassical aspects of differential VDR activation: implications for survival in patients with CKD. Drugs. 2007; 67: 1999-2012.
    • (2007) Drugs , vol.67 , pp. 1999-2012
    • Andress, D.1
  • 20
    • 0026949697 scopus 로고
    • 1,25D3 inhibits cytokine production by human blood monocytes at the posttranscriptional level
    • Muller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K. 1,25D3 inhibits cytokine production by human blood monocytes at the posttranscriptional level. Cytokine. 1992; 4: 506-512.
    • (1992) Cytokine , vol.4 , pp. 506-512
    • Muller, K.1    Haahr, P.M.2    Diamant, M.3    Rieneck, K.4    Kharazmi, A.5    Bendtzen, K.6
  • 22
    • 0036073755 scopus 로고    scopus 로고
    • 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system
    • Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110: 229-238.
    • (2002) J Clin Invest , vol.110 , pp. 229-238
    • Li, Y.C.1    Kong, J.2    Wei, M.3    Chen, Z.F.4    Liu, S.Q.5    Cao, L.P.6
  • 24
    • 0030700528 scopus 로고    scopus 로고
    • Association of calcitriol and blood pressure in normotensive men
    • Kristal-Boneh E,FroomP, HarariG,Ribak J. Association of calcitriol and blood pressure in normotensive men. Hypertension. 1997; 30: 1289-1294.
    • (1997) Hypertension , vol.30 , pp. 1289-1294
    • Kristal-Boneh, E.1    Froom, P.2    Harari, G.3    Ribak, J.4
  • 25
    • 20444441550 scopus 로고    scopus 로고
    • Relationship between fasting serum glucose, age, body mass index and serum25D in postmenopausal women
    • Need AG, O'Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum25D in postmenopausal women. Clin Endocrinol (Oxf). 2005; 62: 738-741.
    • (2005) Clin Endocrinol (Oxf) , vol.62 , pp. 738-741
    • Need, A.G.1    O'Loughlin, P.D.2    Horowitz, M.3    Nordin, B.E.4
  • 27
    • 41449084839 scopus 로고    scopus 로고
    • Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
    • Gutiérrez OMI, Andress DL, Levin A, Wolf M. Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int. 2008; 73: 956-962.
    • (2008) Kidney Int , vol.73 , pp. 956-962
    • Gutiérrez, O.M.I.1    Andress, D.L.2    Levin, A.3    Wolf, M.4
  • 29
    • 10644280669 scopus 로고    scopus 로고
    • VitaminDinsufficiency and deficiency in CKD. A single center observational study
    • Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ. VitaminDinsufficiency and deficiency in CKD.A single center observational study. Am J Nephrol. 2004; 24: 503-510.
    • (2004) Am J Nephrol , vol.24 , pp. 503-510
    • Gonzalez, E.A.1    Sachdeva, A.2    Oliver, D.A.3    Martin, K.J.4
  • 31
    • 0019986588 scopus 로고
    • Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1ahydroxylase in the rat kidney
    • Kawashima H, Kraut JA, Kurokawa K. Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1ahydroxylase in the rat kidney. J Clin Invest. 1982; 70: 135-140.
    • (1982) J Clin Invest , vol.70 , pp. 135-140
    • Kawashima, H.1    Kraut, J.A.2    Kurokawa, K.3
  • 38
    • 0021748474 scopus 로고
    • Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients
    • Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest. 1984; 74: 2136-2143.
    • (1984) J Clin Invest , vol.74 , pp. 2136-2143
    • Slatopolsky, E.1    Weerts, C.2    Thielan, J.3    Horst, R.4    Harter, H.5    Martin, K.J.6
  • 42
    • 34548634762 scopus 로고    scopus 로고
    • Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials
    • Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007; 167: 1730-1737.
    • (2007) Arch Intern Med , vol.167 , pp. 1730-1737
    • Autier, P.1    Gandini, S.2
  • 44
    • 46249115642 scopus 로고    scopus 로고
    • 3-dependent regulation of the renin-angiotensin system in 1a-hydroxylase-/-mice
    • 3-dependent regulation of the renin-angiotensin system in 1a-hydroxylase-/-mice. Kidney Int. 2008; 74: 170-179.
    • (2008) Kidney Int , vol.74 , pp. 170-179
    • Zhou, C.1    Lu, F.2    Cao, K.3    Xu, D.4    Goltzman, D.5    Miao, D.6
  • 45
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI. clinical practice guidelines for chronic kidney disease
    • K/DOQI clinical practice guidelines for chronic kidney disease.AmJ Kidney Dis. 2002; 39: 1-266.
    • (2002) Am J Kidney Dis , vol.39 , pp. 1-266
  • 46
    • 33847669753 scopus 로고    scopus 로고
    • Impact of ergocalciferol treatment of vitamin D deficiency on serum PTH concentrations in CKD
    • Zisman AL, Hristova M, Ho LT, Sprague SM. Impact of ergocalciferol treatment of vitamin D deficiency on serum PTH concentrations in CKD. Am J Nephrol. 2007; 27: 36-43.
    • (2007) Am J Nephrol , vol.27 , pp. 36-43
    • Zisman, A.L.1    Hristova, M.2    Ho, L.T.3    Sprague, S.M.4
  • 47
    • 34250771472 scopus 로고    scopus 로고
    • Changes in serum 25D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD
    • Al-Aly Z, Qazi RA, Gonzalez EA, Zeringue A, Martin KJ. Changes in serum 25D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. AmJ Kidney Dis. 2007; 50: 59-68.
    • (2007) AmJ Kidney Dis , vol.50 , pp. 59-68
    • Al-Aly, Z.1    Qazi, R.A.2    Gonzalez, E.A.3    Zeringue, A.4    Martin, K.J.5
  • 49
    • 8744276604 scopus 로고    scopus 로고
    • Vitamin D2 is much less effective than vitamin D3 in humans
    • Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004; 89: 5387-5391.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 5387-5391
    • Armas, L.A.1    Hollis, B.W.2    Heaney, R.P.3
  • 50
    • 32444447064 scopus 로고    scopus 로고
    • The impact of over-the-counter vitamin D supplements on vitamin D and parathyroid hormone levels in chronic kidney disease
    • Sekkarie M. The impact of over-the-counter vitamin D supplements on vitamin D and parathyroid hormone levels in chronic kidney disease. Clin Nephrol. 2006; 65: 91-96.
    • (2006) Clin Nephrol , vol.65 , pp. 91-96
    • Sekkarie, M.1
  • 55
    • 33644946514 scopus 로고    scopus 로고
    • ASN2005 Poster # TH-PO735
    • Young E. ASN2005 Poster # TH-PO735. JAmSoc Nephrol. 2005; 16: 278.
    • (2005) JAmSoc Nephrol , vol.16 , pp. 278
    • Young, E.1
  • 59
    • 33846808897 scopus 로고    scopus 로고
    • Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients
    • Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract. 2007; 105: 132-138.
    • (2007) Nephron Clin Pract , vol.105 , pp. 132-138
    • Saab, G.1    Young, D.O.2    Gincherman, Y.3    Giles, K.4    Norwood, K.5    Coyne, D.W.6
  • 60
    • 0022959490 scopus 로고
    • Influence of vitamin D or its metabolites on the rate of progression of chronic renal failure
    • Froehling PT, Kokot K, Vetter K, Kaschube I, Lindenau K. Influence of vitamin D or its metabolites on the rate of progression of chronic renal failure. Contrib Nephrol. 1986; 53: 64-70.
    • (1986) Contrib Nephrol , vol.53 , pp. 64-70
    • Froehling, P.T.1    Kokot, K.2    Vetter, K.3    Kaschube, I.4    Lindenau, K.5
  • 66
    • 31744439280 scopus 로고    scopus 로고
    • 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression
    • Li Y, Spataro BC, Yang J, Dai C, Liu Y. 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int. 2005; 68: 1500-1510.
    • (2005) Kidney Int , vol.68 , pp. 1500-1510
    • Li, Y.1    Spataro, B.C.2    Yang, J.3    Dai, C.4    Liu, Y.5
  • 69
    • 70349251198 scopus 로고    scopus 로고
    • Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial
    • Fishbane S, Chittineni H, Packman M, Dutka P, Ali N, Durie N. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. Am J Kidney Dis. 2009; 54: 647-652.
    • (2009) Am J Kidney Dis , vol.54 , pp. 647-652
    • Fishbane, S.1    Chittineni, H.2    Packman, M.3    Dutka, P.4    Ali, N.5    Durie, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.